Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nepadutant in treatment-refractory infant colic
2010-022706-41Phase 2Terminated
- Sponsor
- Menarini Group
- Start
- Dec 2010
- Modality
- Cyclic Peptides → Modified Peptides → Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nepadutant in baby colic (3 arms), sponsored by Menarini Group. Primary endpoint: Primary efficacy endpoint. Started Dec 2010; status: terminated.
02
Drugs
nepadutant
03
Conditions
baby colic
Beyond the preview
Go deeper on 2010-022706-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022706-41.